Coleman, Robert L <br/><br/>
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.  [electronic resource] 

 -  Lancet (London, England)  Oct 2017 
 - 1949-1961 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(17)32440-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Indoles--administration & dosage<br/>Internationality<br/>Maintenance Chemotherapy--methods<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--mortality<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Risk Assessment<br/>Survival Rate<br/>Treatment Outcome